Stereotactic Radiotherapy for Stage I Small Cell Lung Cancer

Although the use of stereotactic ablative radiotherapy (SABR) for stage I small cell lung cancer is in its infancy, there are many reasons to believe that with more time and experience, it could emerge as the standard of care in inoperable patients, and perhaps even have equipoise with surgery for operable patients. Reporting of modeling studies and as much clinical data as possible are very much needed.

[1]  Y. Shibamoto,et al.  Multi-institutional Retrospective Study of Stereotactic Body Radiation Therapy for Stage I Small Cell Lung Cancer: Japan Radiation Oncology Study Group (JROSG) , 2015 .

[2]  S. Beriwal,et al.  Medicare Approves Coverage for Lung Cancer Screening: The Case for Symptomatic Screening. , 2015, JAMA oncology.

[3]  V. Verma.  Stereotactic Radiotherapy Versus Surgery for Early-Stage Operable Lung Cancer: More Questions Than Answers. , 2015, The Journal of the National Comprehensive Cancer Network.

[4]  W. Zhen,et al.  Treatment Costs of Early-Stage Lung Cancers Detected by Low-Dose Computed Tomography Screening. , 2015, International journal of radiation oncology, biology, physics.

[5]  Peter Balter,et al.  Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. , 2015, The Lancet. Oncology.

[6]  V. Verma.  Lung cancer: Implementing lung-cancer screening—oncological 'grey areas' , 2015, Nature Reviews Clinical Oncology.

[7]  Joe Y. Chang,et al.  Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly. , 2014, JAMA surgery.

[8]  Dong Wang,et al.  Stereotactic body radiotherapy with concurrent chemotherapy extends survival of patients with limited stage small cell lung cancer: a single-center prospective phase II study , 2014, Medical Oncology.

[9]  Steven H. Lin,et al.  Stereotactic body radiation therapy for stage I small cell lung cancer: a single institutional case series and review of the literature , 2014, Journal of Radiation Oncology.

[10]  C. Reddy,et al.  Stereotactic body radiation therapy-based treatment model for stage I medically inoperable small cell lung cancer. , 2013, Practical radiation oncology.

[11]  C. Simone,et al.  Stereotactic body radiation therapy for lung cancer. , 2013, Chest.

[12]  James M. Galvin,et al.  RTOG 0618: Stereotactic body radiation therapy (SBRT) to treat operable early-stage lung cancer patients. , 2013 .

[13]  Suresh Senan,et al.  Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis. , 2012, The Lancet. Oncology.

[14]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[15]  Hiroshi Honda,et al.  Clinical results of stereotactic body radiotherapy for Stage I small-cell lung cancer: a single institutional experience , 2010, Journal of radiation research.

[16]  R. Onimaru,et al.  A Phase II Trial of Stereotactic Body Radiation Therapy for Operable T1N0M0 Non-small Cell Lung Cancer: Japan Clinical Oncology Group (JCOG0403) , 2010 .

[17]  Alfons G H Kessels,et al.  Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  Andrea Bezjak,et al.  Stereotactic body radiation therapy for inoperable early stage lung cancer. , 2010, JAMA.

[19]  T. Strand,et al.  Small cell lung cancer in Norway. Should more patients have been offered surgical therapy? , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[20]  S. Miyoshi,et al.  Surgical results for small cell lung cancer based on the new TNM staging system. Thoracic Surgery Study Group of Osaka University, Osaka, Japan. , 2000, The Annals of thoracic surgery.

[21]  G. Giaccone,et al.  A prospective randomized trial to determine the benefit of surgical resection of residual disease following response of small cell lung cancer to combination chemotherapy. , 1994, Chest.

[22]  W. Fox,et al.  Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of bronchus. Ten-year follow-up. , 1973, Lancet.

[23]  R. A. Green,et al.  Alkylating agents in bronchogenic carcinoma. , 1969, The American journal of medicine.

[24]  Ping Wang,et al.  Factors affecting the risk of brain metastasis in small cell lung cancer with surgery: is prophylactic cranial irradiation necessary for stage I-III disease? , 2013, International journal of radiation oncology, biology, physics.